Clene
Phase 1We are a clinical-stage biopharmaceutical company dedicated to revolutionizing the treatment of neurodegenerative diseases to restore and protect neuronal health and function. Our nanotherapeutics target cellular energy impairments that are common to many diseases.
Founded
2013
Employees
1-10
Focus
Nanotechnology
About
We are a clinical-stage biopharmaceutical company dedicated to revolutionizing the treatment of neurodegenerative diseases to restore and protect neuronal health and function. Our nanotherapeutics target cellular energy impairments that are common to many diseases.
Funding History
3Total raised: $90M
PIPE$40MUndisclosedJun 15, 2021
IPO$25MIPODec 30, 2020
Series A$25MUndisclosedMar 15, 2018
Company Info
TypePrivate
Founded2013
Employees1-10
LocationSalt Lake City, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile